Cytologic evaluation of bronchoalveolar lavage fluid from horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively.

This study examined how two types of medication, aerosolized beclomethasone dipropionate and parenterally administered dexamethasone, affect lung inflammation in horses with repeated bouts of respiratory obstruction. The outcomes of the study indicated that both medications reduce inflammation but don’t provide long-term benefits without reducing exposure to environmental allergens.

Research Methodology

• The study was conducted on six horses diagnosed with heaves, a disease condition that could be readily induced and reverted.
• Episodes of heaves were precipitated by exposing the horses to moldy hay and straw for a week.
• Following the induction of the disease, the horses were grouped in three treatment categories: those receiving aerosolized beclomethasone, those given dexamethasone through parenteral administration, and the third group being administered aerosolized propellant.
• The researchers studied pulmonary inflammation in the horses over a period of three weeks by periodically collecting samples of bronchoalveolar lavage (BAL) fluid.
• Cell count of different types and phenotypic analysis of lymphocyte subpopulations in the BAL fluid were performed.

Study Findings

• The week-long exposure to moldy straw and hay caused neutrophilic inflammation across the subject group.
• The researchers noted reduced neutrophil counts in the BAL fluid of the horses given beclomethasone and dexamethasone on the tenth and fourteenth days. By day 21, the counts had risen back to pretreatment values.
• In propellant-treated horses, there was a marked increase in the proportion of proinflammatory lymphocyte subpopulations (CD4+ and B+) and MHC class-II antigens on the fourteenth and twenty-first days. A different narrative was observed in the horses administered with beclomethasone and dexamethasone, as they demonstrated no such trends.

Conclusions

• The administration of aerosolized beclomethasone lessened the neutrophilic lung inflammation and forestalled alteration in lymphocyte subpopulations in the horses suffering from heaves. The impact was comparable to that produced by dexamethasone administered parenterally.
• The study, however, points out that without reducing environmental allergen exposure, administering aerosolized beclomethasone may not yield prolonged anti-inflammatory benefits in horses with repeated bouts of airway obstruction.